X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
multiple myeloma (8) 8
female (7) 7
humans (7) 7
male (7) 7
middle aged (6) 6
oncology (6) 6
aged (5) 5
hematology (4) 4
stem cell transplantation (4) 4
adult (3) 3
autologous peripheral blood stem cell transplantation (3) 3
bortezomib (3) 3
index medicus (3) 3
thalidomide (3) 3
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
apoptosis (2) 2
bone diseases (2) 2
bone marrow (2) 2
canals and inland navigation. waterways (2) 2
cells (2) 2
cryoglobulins (2) 2
disease (2) 2
global (2) 2
hematologic neoplasms - drug therapy (2) 2
hematologic neoplasms - pathology (2) 2
high dose chemotherapy (2) 2
immunosuppressive agents - therapeutic use (2) 2
interleukin-2 - therapeutic use (2) 2
monoclonal gammopathy (2) 2
multiple myeloma - drug therapy (2) 2
multiple myeloma - therapy (2) 2
observational study (2) 2
ril-2 therapy (2) 2
routine practice (2) 2
survival (2) 2
survival analysis (2) 2
therapy (2) 2
transplantation, autologous (2) 2
transportation and communications (2) 2
treatment outcome (2) 2
trial (2) 2
ulcers (2) 2
zoledronic acid (2) 2
2-cda (1) 1
2-cda. chlorodeoxyadenosine (1) 1
2cda therapy (1) 1
[ sdv ] life sciences [q-bio] (1) 1
acids (1) 1
acquired haemophilia (1) 1
allergy (1) 1
antibody against factor viii (1) 1
antilipemic agents (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents, hormonal - adverse effects (1) 1
antineoplastic agents, hormonal - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
autoantibodies - blood (1) 1
autografts (1) 1
b-chronic lymphocytic leukemia (1) 1
b-cll (1) 1
beta (1) 1
biochemistry & molecular biology (1) 1
biosimilar drugs (1) 1
bisphosphonates (1) 1
bleeding (1) 1
blood coagulation factor inhibitors - blood (1) 1
bone density conservation agents - adverse effects (1) 1
bone density conservation agents - therapeutic use (1) 1
bone neoplasms - complications (1) 1
bone neoplasms - mortality (1) 1
bone neoplasms - prevention & control (1) 1
bone neoplasms - secondary (1) 1
cancer therapies (1) 1
care and treatment (1) 1
carfilzomib (1) 1
cd 4 (1) 1
cd 4 depletion (1) 1
cd3 complex - analysis (1) 1
cd4 antigens - analysis (1) 1
cd8 antigens - analysis (1) 1
cell biology (1) 1
chlorodeoxyadenosine (1) 1
chronic lymphocytic leukemia (1) 1
chronic lymphocytic-leukemia (1) 1
cladribine - therapeutic use (1) 1
clinical trials (1) 1
combined modality therapy (1) 1
complete remission (1) 1
complications and side effects (1) 1
computed radiography (1) 1
cytokine production (1) 1
cytokines (1) 1
cytology (1) 1
denosumab (1) 1
denosumab - adverse effects (1) 1
denosumab - therapeutic use (1) 1
depletion (1) 1
dermatology (1) 1
development and progression (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


TransNav, the International Journal on Marine Navigation and Safety of Sea Transportation, ISSN 2083-6473, 2016, Volume 10, Issue 4, pp. 575 - 579
In this paper author summarizes present maritime industry growing preference for highly qualified officers in the field of ECDIS operation. Current ECDIS... 
SOLAS Convention | STCW Convention | IMO Model Course | ECDIS Generic Course | ECDIS Training | Manila Amendments to the STCW | Electronic Chart Display and Information System (ECDIS) | Maritime Industry
Journal Article
TransNav, the International Journal on Marine Navigation and Safety of Sea Transportation, ISSN 2083-6473, 2016, Volume 10, Issue 1, pp. 105 - 113
In this paper author suggest methods for position cross-checking on modern bridge equipped with ECDIS. Terrestrial navigation techniques in relation to newly... 
OCIMF Recommendations | Duties and Responsibilities of the Officer on Watch | GPS Position | Ship Inspection Report Programme (SIRE) | ECDIS | Safety Management System | Position Cross-Checking | Japan Radio Company (JRC)
Journal Article
The Lancet Oncology, ISSN 1470-2045, 03/2018, Volume 19, Issue 3, pp. 370 - 381
Journal Article
by Mohty, Mohamad and Terpos, Evangelos and Mateos, Maria-Victoria and Cavo, Michele and Lejniece, Sandra and Beksac, Meral and Bekadja, Mohamed Amine and Legiec, Wojciech and Dimopoulos, Meletios and Stankovic, Svetlana and Durán, Maria Soledad and De Stefano, Valerio and Corso, Alessandro and Kochkareva, Yulia and Laane, Edward and Berthou, Christian and Salwender, Hans and Masliak, Zvenyslava and Pečeliūnas, Valdas and Willenbacher, Wolfgang and Silva, João and Louw, Vernon and Nemet, Damir and Borbényi, Zita and Abadi, Uri and Pedersen, Robert Schou and Černelč, Peter and Potamianou, Anna and Couturier, Catherine and Feys, Caroline and Thoret-Bauchet, Florence and Boccadoro, Mario and Bekadja, Mohamed and Hamladji, Rose-Marie and Ali, Hocine Ait and Hamdi, Selma and Touhami, Hadj and Mansour, Nourredine Sidi and Linkesch, Werner and Abildgaard, Niels and Hein, Marju and Eveillard, Jean Richard and Yamani, Abderrazak el and Moreau, Philippe and Sanhes, Laurence and Lepeu, Gérard and Laribi, Kamel and Jourdan, Eric and Fitoussi, Olivier and Allangba, Olivier and Fleury, Joël and Escoffre, Martine and Benramdane, Riad and Cartron, Guillaume and Dine, Gérard and Legouffe, Eric and Harich, Hanns-Detlev and Illmer, Thomas and Dörfel, Steffen and Hannig, Carla Verena and Koenigsmann, Michael and Prange-Krex, Gabriele and Tamm, Ingo and Zeller, Wolfgang and Maasberg, Michael and Schlag, Rudolf and Klausmann, Martine and Uhlig, Jens and Alkemper, Burkhard and Schütz, Stefan and Tessen, Hans-Werner and Mohr, Benno and Schmidt, Peter and Heinrich, Bernhard and Hebart, Holger and Seipelt, Gernot and Zoeller, Thomas and Heits, Frank and Müller-Naendrup, Clemens and Hansen, Richard and Repp, Roland and Von Weikersthal, Ludwig Fischer and Schmits, Rudolf and Heßling, Jörg and Krammer-Steiner, B and Janzen, Viktor and Schauer, Michael and Grüner, Marcus W and Kisro, Jens and Denzlinger, Claudio and Freier, Werner and Junghanss, Christian and Görner, Martin and Laichinger, Katharina and Ostermann, Helmut and Dürk, Heinz and Hess, Georg and Reich, Gernot and Matsouka, Panagiota and Pouli, Anastasia and ... and EMMOS Investigators
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 10/2018, Volume 18, Issue 10, pp. e401 - e419
Multiple myeloma (MM) remains an incurable disease, with little information available on its management in real-world clinical practice. The results of the... 
Stem cell transplantation | Observational study | Bortezomib | Routine practice | Global | UNITED-STATES | SURVIVAL | GUIDELINES | INDUCTION | PLUS DEXAMETHASONE | ONCOLOGY | TREATMENT PATTERNS | THERAPIES | STEM-CELL TRANSPLANTATION | HEMATOLOGY
Journal Article
Biocybernetics and Biomedical Engineering, ISSN 0208-5216, 04/2019, Volume 39, Issue 2, pp. 328 - 338
The radiological test is cost-effective, widely available, allows for the visualisation of large areas of the skeleton and can identify long bones potentially... 
Feature selection | Computed radiography | Hellwig's method | Texture classification | Multiple myeloma | MULTIPLE-MYELOMA | DIAGNOSIS | MANAGEMENT | ENGINEERING, BIOMEDICAL | DISEASE | PET/CT | STATISTICAL PATTERN-RECOGNITION
Journal Article
Annals of Hematology, ISSN 0939-5555, 10/2011, Volume 90, Issue 10, pp. 1161 - 1166
The treatment of patients with multiple myeloma usually includes many drugs including thalidomide, lenalidomide and bortezomib. Lovastatin and other inhibitors... 
Medicine & Public Health | Hematology | Multiple myeloma | Oncology | Lovastatin | Thalidomide | Apoptosis | RESISTANT | LOW-DOSE THALIDOMIDE | INHIBITION | INDUCED APOPTOSIS | MEVALONATE PATHWAY | HEMATOLOGY | PLASMA-CELLS | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Salvage Therapy - adverse effects | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Dexamethasone - adverse effects | Drug Resistance, Neoplasm | Male | Multiple Myeloma - immunology | Transplantation, Autologous | Neoplasm Recurrence, Local - immunology | Stem Cell Transplantation | Antineoplastic Agents, Hormonal - adverse effects | Multiple Myeloma - drug therapy | Multiple Myeloma - therapy | Antineoplastic Agents, Hormonal - therapeutic use | Female | Lovastatin - administration & dosage | Immunosuppressive Agents - administration & dosage | Lovastatin - therapeutic use | Thalidomide - adverse effects | Dexamethasone - administration & dosage | Immunomodulation | Lovastatin - adverse effects | Neoplasm Recurrence, Local - therapy | Thalidomide - administration & dosage | Dexamethasone - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Survival Analysis | Immunosuppressive Agents - adverse effects | Aged | Thalidomide - therapeutic use | Medical colleges | Care and treatment | Relapse | Dexamethasone | Transplantation | Diseases | Antilipemic agents | Stem cells | Bone marrow | Steroids | Drugs | Autografts | Bortezomib | stem cell transplantation | Tumor cell lines | Immunosuppressive agents | Side effects | Plasma cells | Hydroxymethylglutaryl-CoA reductase | Original
Journal Article
Acta Haematologica Polonica, ISSN 0001-5814, 2014, Volume 45, Issue 2, pp. 132 - 136
Despite the significant progress that has been made in recent years in the treatment of chronic lymphocytic leukemia (CLL), mainly due to the introduction of... 
Chronic Lymphocytic Leukemia | Minimal Residual Disease | Hematopoietic Stem Cell Transplantation
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 5321 - 5321
Abstract Abstract 5321 OBJECTIVES: Granulocyte colony-stimulating factors (G-CSFs) are widely used to accelerate haematopoietic recovery after bone marrow... 
Journal Article
Wspolczesna Onkologia, ISSN 1428-2526, 2014, Volume 18, Issue 1, pp. 17 - 21
Carfilzomib (CFZ), an epoxyketone with specific chymotrypsin-like activity, is a second-generation proteasome inhibitor with significant activity in patients... 
Carfilzomib | Pomalidomide | Treatment | Multiple myeloma | treatment | multiple myeloma | ONCOLOGY | pomalidomide | carfilzomib | Review
Journal Article
Wspólczesna Onkologia, ISSN 1428-2526, 01/2014, Volume 18, Issue 1, p. 17
  Carfilzomib (CFZ), an epoxyketone with specific chymotrypsin-like activity, is a second-generation proteasome inhibitor with significant activity in patients... 
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 3236 - 3236
Abstract The aim of the multi-centre observational study was to evaluate the efficacy of lenalidomide (len) therapy in patients (pts) with resistant or... 
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 5125 - 5125
Abstract Abstract 5125 The aim of the multi-centre observational study was to evaluate the efficacy and safety of lenalidomide therapy in patients with... 
Journal Article
Folia Histochemica et Cytobiologica, ISSN 0239-8508, 07/2011, Volume 49, Issue 2, pp. 248 - 254
Patients with multiple myeloma (MM) treated with conventional chemotherapy have an average survival of approximately three years. High dose chemotherapy... 
high dose chemotherapy | autologous peripheral blood stem cell transplantation | multiple myeloma
Journal Article
POSTEPY DERMATOLOGII I ALERGOLOGII, ISSN 1642-395X, 2011, Volume 28, Issue 2, pp. 145 - 149
Cryoglobulinaemia is characterized by the presence of cryoglobulins in serum, which precipitate at temperatures below 37 degrees C and dissolve on warming.... 
cryoglobulins | ALLERGY | ulcers | monoclonal gammopathy | DISEASE | DERMATOLOGY
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.